Review





Similar Products

90
Reliatech primary rabbit cd31 polyclonal antibody
Primary Rabbit Cd31 Polyclonal Antibody, supplied by Reliatech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+rabbit+polyclonal+antibody+cd31/rabbit+anti+cd31+polyclonal+antibody/pm39951953-167-10-16
Average 90 stars, based on 1 article reviews
primary rabbit cd31 polyclonal antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

96
Novus Biologicals polyclonal rabbit anti human cd31 primary antibody
Polyclonal Rabbit Anti Human Cd31 Primary Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+rabbit+polyclonal+antibody+cd31/CD31%2FPECAM-1+Antibody/10__1071_slash_rd24118-94-6-14
Average 96 stars, based on 1 article reviews
polyclonal rabbit anti human cd31 primary antibody - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Proteintech rabbit anti mouse cd31 polyclonal primary antibody
Rabbit Anti Mouse Cd31 Polyclonal Primary Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+rabbit+polyclonal+antibody+cd31/Cd31+Polyclonal+antibody/pmc11966767__nn4c14057_si_001-65-8-17
Average 96 stars, based on 1 article reviews
rabbit anti mouse cd31 polyclonal primary antibody - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

90
Reliatech primary antibody anti-rabbit cd31 polyclonal antibody
Primary Antibody Anti Rabbit Cd31 Polyclonal Antibody, supplied by Reliatech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+rabbit+polyclonal+antibody+cd31/rabbit+anti+cd31+polyclonal+antibody/pm37379527-277-39-45
Average 90 stars, based on 1 article reviews
primary antibody anti-rabbit cd31 polyclonal antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

99
Danaher Inc rabbit polyclonal primary antibody to cd31
Macroscopic observation, Histological staining (H&E) and Immunofluorescence staining <t>(CD31)</t> of subcutaneously implanted P:P and P:P:Bs grafts. H&E and CD31 staining showing accelerated angiogenesis (arrows) in P:P:B1 and P:P:B2 grafts. Despite high angiogenesis in P:P:B3 graft, the inflammatory response was observed.
Rabbit Polyclonal Primary Antibody To Cd31, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+rabbit+polyclonal+antibody+cd31/Rabbit+Polyclonal+Anti-JAK2+(phospho+Y1007)+antibody/pmc10232732-237-8-16
Average 99 stars, based on 1 article reviews
rabbit polyclonal primary antibody to cd31 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

90
Thermo Fisher primary antibody rabbit polyclonal cd31 antibody
Plated cell types: human cardiac microvascular endothelial cells (hCMEC, PromoCell), hBEC (Lonza HMVEC-dBLAD), hLEC (Cascade HMVECad), and human dermal lymphatic endothelial cells (hDLEC, PromoCell) immuno-stained for hCD31 (left hand panel) podoplanin (middle panel). DAPI: blue nuclei. Corresponding bright field images of <t>CD31</t> and podoplanin immuno-stained cells appear to the right of each immuno-stained image. The right panel indicates a negative control with DAPI (blue nuclei) staining. Scale bar = 50 µm in each image.
Primary Antibody Rabbit Polyclonal Cd31 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+rabbit+polyclonal+antibody+cd31/cd31+antibody/pmc09806376-79-6-11
Average 90 stars, based on 1 article reviews
primary antibody rabbit polyclonal cd31 antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

99
Danaher Inc primary rabbit polyclonal anti cd31 antibody
A Schematic representation of in vivo experiments. GFP-positive Caki-1 cells were treated with drugs constantly for 3 weeks. After a 7-day break to increase the cell number, cells were treated for the next 7 days. Next, resistant cells were harvested and mixed with wild-type Caki-1 in a 1:1 ratio and injected subcutaneously into NOD-SCID mice. B Effect of drug resistance on tumor volume (left graph) and tumor weight (right graph). control, N = 18; sunitinib, N = 16; sorafenib, N = 18. C mRNA analysis of lung metastasis using real-time PCR. N = 17 for each group except sorafenib, N = 18. D Representative merged images of bright-field and GFP fluorescence (upper panel) or only GFP fluorescence (lower panel) of tumor sections E Percentage quantification of GFP-positive tumor area to total tumor area in tumor sections, N = 6 control; N = 8 sunitinib; N = 7 sorafenib. F Percentage of tumor-free mice after cancer-cell injection. P value summary ** calculated with Log-rank (Mantel–Cox) test, N = 18 per group. G , H Representative images after immunofluorescence staining of <t>CD31</t> ( G ) and ICAM-1 ( H ). I CD31 IHC staining of tumor sections and quantification of functional vessels with a visible lumen. J mRNA level of MMP9 and IL8 in tumors, quantified with real-time PCR. IL8 , N = 10 per group, MMP9 , N = 5. K The level of secreted IL8 in mouse plasma obtained using ELISA, N = 8 per group. Tumors were collected 6 weeks after s.c. injection of RCC cells. The results are presented as the mean ± SEM. P values were estimated using One-way ANOVA with post hoc Tukey’s multiple comparison test, except MMP9 where the Student’s t test was used. * P < 0.05; ** P < 0.01.
Primary Rabbit Polyclonal Anti Cd31 Antibody, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+rabbit+polyclonal+antibody+cd31/Rabbit+Polyclonal+Anti-JAK2+(phospho+Y1007)+antibody/pmc09500022-154-6-12
Average 99 stars, based on 1 article reviews
primary rabbit polyclonal anti cd31 antibody - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

86
Danaher Inc rabbit polyclonal cd31 primary antibody
A Schematic representation of in vivo experiments. GFP-positive Caki-1 cells were treated with drugs constantly for 3 weeks. After a 7-day break to increase the cell number, cells were treated for the next 7 days. Next, resistant cells were harvested and mixed with wild-type Caki-1 in a 1:1 ratio and injected subcutaneously into NOD-SCID mice. B Effect of drug resistance on tumor volume (left graph) and tumor weight (right graph). control, N = 18; sunitinib, N = 16; sorafenib, N = 18. C mRNA analysis of lung metastasis using real-time PCR. N = 17 for each group except sorafenib, N = 18. D Representative merged images of bright-field and GFP fluorescence (upper panel) or only GFP fluorescence (lower panel) of tumor sections E Percentage quantification of GFP-positive tumor area to total tumor area in tumor sections, N = 6 control; N = 8 sunitinib; N = 7 sorafenib. F Percentage of tumor-free mice after cancer-cell injection. P value summary ** calculated with Log-rank (Mantel–Cox) test, N = 18 per group. G , H Representative images after immunofluorescence staining of <t>CD31</t> ( G ) and ICAM-1 ( H ). I CD31 IHC staining of tumor sections and quantification of functional vessels with a visible lumen. J mRNA level of MMP9 and IL8 in tumors, quantified with real-time PCR. IL8 , N = 10 per group, MMP9 , N = 5. K The level of secreted IL8 in mouse plasma obtained using ELISA, N = 8 per group. Tumors were collected 6 weeks after s.c. injection of RCC cells. The results are presented as the mean ± SEM. P values were estimated using One-way ANOVA with post hoc Tukey’s multiple comparison test, except MMP9 where the Student’s t test was used. * P < 0.05; ** P < 0.01.
Rabbit Polyclonal Cd31 Primary Antibody, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+rabbit+polyclonal+antibody+cd31/pm35487064-315-17-23
Average 86 stars, based on 1 article reviews
rabbit polyclonal cd31 primary antibody - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
Thermo Fisher rabbit anti-cd31 polyclonal primary antibody
A Schematic representation of in vivo experiments. GFP-positive Caki-1 cells were treated with drugs constantly for 3 weeks. After a 7-day break to increase the cell number, cells were treated for the next 7 days. Next, resistant cells were harvested and mixed with wild-type Caki-1 in a 1:1 ratio and injected subcutaneously into NOD-SCID mice. B Effect of drug resistance on tumor volume (left graph) and tumor weight (right graph). control, N = 18; sunitinib, N = 16; sorafenib, N = 18. C mRNA analysis of lung metastasis using real-time PCR. N = 17 for each group except sorafenib, N = 18. D Representative merged images of bright-field and GFP fluorescence (upper panel) or only GFP fluorescence (lower panel) of tumor sections E Percentage quantification of GFP-positive tumor area to total tumor area in tumor sections, N = 6 control; N = 8 sunitinib; N = 7 sorafenib. F Percentage of tumor-free mice after cancer-cell injection. P value summary ** calculated with Log-rank (Mantel–Cox) test, N = 18 per group. G , H Representative images after immunofluorescence staining of <t>CD31</t> ( G ) and ICAM-1 ( H ). I CD31 IHC staining of tumor sections and quantification of functional vessels with a visible lumen. J mRNA level of MMP9 and IL8 in tumors, quantified with real-time PCR. IL8 , N = 10 per group, MMP9 , N = 5. K The level of secreted IL8 in mouse plasma obtained using ELISA, N = 8 per group. Tumors were collected 6 weeks after s.c. injection of RCC cells. The results are presented as the mean ± SEM. P values were estimated using One-way ANOVA with post hoc Tukey’s multiple comparison test, except MMP9 where the Student’s t test was used. * P < 0.05; ** P < 0.01.
Rabbit Anti Cd31 Polyclonal Primary Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+rabbit+polyclonal+antibody+cd31/cd31+antibody/pm35032535-100-22-27
Average 90 stars, based on 1 article reviews
rabbit anti-cd31 polyclonal primary antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Macroscopic observation, Histological staining (H&E) and Immunofluorescence staining (CD31) of subcutaneously implanted P:P and P:P:Bs grafts. H&E and CD31 staining showing accelerated angiogenesis (arrows) in P:P:B1 and P:P:B2 grafts. Despite high angiogenesis in P:P:B3 graft, the inflammatory response was observed.

Journal: Materials Today Bio

Article Title: Tissue-engineered small-diameter vascular grafts containing novel copper-doped bioactive glass biomaterials to promote angiogenic activity and endothelial regeneration

doi: 10.1016/j.mtbio.2023.100647

Figure Lengend Snippet: Macroscopic observation, Histological staining (H&E) and Immunofluorescence staining (CD31) of subcutaneously implanted P:P and P:P:Bs grafts. H&E and CD31 staining showing accelerated angiogenesis (arrows) in P:P:B1 and P:P:B2 grafts. Despite high angiogenesis in P:P:B3 graft, the inflammatory response was observed.

Article Snippet: Following overnight incubation at 4 ​°C with a rabbit polyclonal primary antibody to CD31 (Ab28364, 1:100, Abcam, USA), the samples were incubated with a goat anti-rabbit IgG H&L secondary antibody (1:50, Abcam, USA) at room temperature for 90 ​min.

Techniques: Staining, Immunofluorescence

Plated cell types: human cardiac microvascular endothelial cells (hCMEC, PromoCell), hBEC (Lonza HMVEC-dBLAD), hLEC (Cascade HMVECad), and human dermal lymphatic endothelial cells (hDLEC, PromoCell) immuno-stained for hCD31 (left hand panel) podoplanin (middle panel). DAPI: blue nuclei. Corresponding bright field images of CD31 and podoplanin immuno-stained cells appear to the right of each immuno-stained image. The right panel indicates a negative control with DAPI (blue nuclei) staining. Scale bar = 50 µm in each image.

Journal: Journal of Tissue Engineering

Article Title: Engineering transplantable human lymphatic and blood capillary networks in a porous scaffold

doi: 10.1177/20417314221140979

Figure Lengend Snippet: Plated cell types: human cardiac microvascular endothelial cells (hCMEC, PromoCell), hBEC (Lonza HMVEC-dBLAD), hLEC (Cascade HMVECad), and human dermal lymphatic endothelial cells (hDLEC, PromoCell) immuno-stained for hCD31 (left hand panel) podoplanin (middle panel). DAPI: blue nuclei. Corresponding bright field images of CD31 and podoplanin immuno-stained cells appear to the right of each immuno-stained image. The right panel indicates a negative control with DAPI (blue nuclei) staining. Scale bar = 50 µm in each image.

Article Snippet: Sections were overlaid with primary antibody (rabbit polyclonal CD31 antibody, 1:50 Thermo Fisher Scientific), mouse monoclonal podoplanin antibody (clone D2-40, 1:100, Dako), mouse monoclonal smooth muscle actin (clone 1A4, 1:100, Dako) diluted in 5% (v/v) goat serum, overnight at 4°C.

Techniques: Staining, Negative Control

A Schematic representation of in vivo experiments. GFP-positive Caki-1 cells were treated with drugs constantly for 3 weeks. After a 7-day break to increase the cell number, cells were treated for the next 7 days. Next, resistant cells were harvested and mixed with wild-type Caki-1 in a 1:1 ratio and injected subcutaneously into NOD-SCID mice. B Effect of drug resistance on tumor volume (left graph) and tumor weight (right graph). control, N = 18; sunitinib, N = 16; sorafenib, N = 18. C mRNA analysis of lung metastasis using real-time PCR. N = 17 for each group except sorafenib, N = 18. D Representative merged images of bright-field and GFP fluorescence (upper panel) or only GFP fluorescence (lower panel) of tumor sections E Percentage quantification of GFP-positive tumor area to total tumor area in tumor sections, N = 6 control; N = 8 sunitinib; N = 7 sorafenib. F Percentage of tumor-free mice after cancer-cell injection. P value summary ** calculated with Log-rank (Mantel–Cox) test, N = 18 per group. G , H Representative images after immunofluorescence staining of CD31 ( G ) and ICAM-1 ( H ). I CD31 IHC staining of tumor sections and quantification of functional vessels with a visible lumen. J mRNA level of MMP9 and IL8 in tumors, quantified with real-time PCR. IL8 , N = 10 per group, MMP9 , N = 5. K The level of secreted IL8 in mouse plasma obtained using ELISA, N = 8 per group. Tumors were collected 6 weeks after s.c. injection of RCC cells. The results are presented as the mean ± SEM. P values were estimated using One-way ANOVA with post hoc Tukey’s multiple comparison test, except MMP9 where the Student’s t test was used. * P < 0.05; ** P < 0.01.

Journal: Cell Death & Disease

Article Title: Resistance to tyrosine kinase inhibitors promotes renal cancer progression through MCPIP1 tumor-suppressor downregulation and c-Met activation

doi: 10.1038/s41419-022-05251-4

Figure Lengend Snippet: A Schematic representation of in vivo experiments. GFP-positive Caki-1 cells were treated with drugs constantly for 3 weeks. After a 7-day break to increase the cell number, cells were treated for the next 7 days. Next, resistant cells were harvested and mixed with wild-type Caki-1 in a 1:1 ratio and injected subcutaneously into NOD-SCID mice. B Effect of drug resistance on tumor volume (left graph) and tumor weight (right graph). control, N = 18; sunitinib, N = 16; sorafenib, N = 18. C mRNA analysis of lung metastasis using real-time PCR. N = 17 for each group except sorafenib, N = 18. D Representative merged images of bright-field and GFP fluorescence (upper panel) or only GFP fluorescence (lower panel) of tumor sections E Percentage quantification of GFP-positive tumor area to total tumor area in tumor sections, N = 6 control; N = 8 sunitinib; N = 7 sorafenib. F Percentage of tumor-free mice after cancer-cell injection. P value summary ** calculated with Log-rank (Mantel–Cox) test, N = 18 per group. G , H Representative images after immunofluorescence staining of CD31 ( G ) and ICAM-1 ( H ). I CD31 IHC staining of tumor sections and quantification of functional vessels with a visible lumen. J mRNA level of MMP9 and IL8 in tumors, quantified with real-time PCR. IL8 , N = 10 per group, MMP9 , N = 5. K The level of secreted IL8 in mouse plasma obtained using ELISA, N = 8 per group. Tumors were collected 6 weeks after s.c. injection of RCC cells. The results are presented as the mean ± SEM. P values were estimated using One-way ANOVA with post hoc Tukey’s multiple comparison test, except MMP9 where the Student’s t test was used. * P < 0.05; ** P < 0.01.

Article Snippet: IHC evaluation was also performed using primary rabbit polyclonal anti-CD31 antibody (1:50, Abcam) and EnVision Detection Systems Peroxidase/DAB, Rabbit/Mouse (DakoCytomation) to visualize tumor vascularization.

Techniques: In Vivo, Injection, Real-time Polymerase Chain Reaction, Fluorescence, Immunofluorescence, Staining, Immunohistochemistry, Functional Assay, Enzyme-linked Immunosorbent Assay